Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?

Journal of Clinical Psychiatry

Volumn 65, Issue 7, 2004, Pages 966-974

  Kleindienst, Nikolaus ^a   Greil, Waldemar ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Psychiatric Private Clinic Sanatorium Kilchberg   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LITHIUM;

ADULT; AGE; ARTICLE; ATTITUDE TO HEALTH; BIPOLAR DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PATIENT; PATIENT COMPLIANCE; PROBABILITY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE FACTORS; ANTICONVULSANTS; ATTITUDE TO HEALTH; BIPOLAR DISORDER; CARBAMAZEPINE; FEMALE; HUMANS; LITHIUM; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PROBABILITY;

EID: 4444273155     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0713     Document Type: Article

References (44)

1. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949;36:349-352
2. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
3. Schou M. The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand 1997;95:361-363 (Pubitemid 27244832)
4. Tondo L, Baldessarini RJ, Hennen J, et al. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998;59:405-414 (Pubitemid 28391562)
5. Greil W, Broucek B, Klein HE, et al. Discontinuation of lithium maintenance therapy: reversibility of clinical, psychological, and neuroendocrinological changes. In: Emrich HM, Aldenhoff JB, Lux HD, et al, eds. Basic Mechanisms in the Action of Lithium. Amsterdam, the Netherlands: Excerpta Medica; 1982:235-248
6. Klein HE, Broucek B, Greil W. Lithium withdrawal triggers psychotic states [letter]. Br J Psychiatry 1981;139:255-256
7. Suppes T, Baldessarini RJ, Faedda GL, et al. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082-1088
8. Colom F, Vieta E, Martínez-Arán A, et al. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000;61:549-555 (Pubitemid 30677968)
9. Hirschfeld RMA. American health care systems and depression: the past, present, and the future. J Clin Psychiatry 1998;59(suppl 20):5-10 (Pubitemid 29001826)
10. Keck PE Jr, McElroy SL, Strakowski SM, et al. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997;33:87-91 (Pubitemid 27184199)
11. Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness: efficacy, effectiveness and efficiency. Br J Psychiatry 1994;164:741-746 (Pubitemid 24186893)
12. Leverich GS, Post RM, Rosoff AS. Factors associated with relapse during maintenance treatment of affective disorders. Int Clin Psychopharmacol 1990;5:135-156
13. Cochran SD, Gitlin MJ. Attitudinal correlates of lithium compliance in bipolar affective disorders. J Nerv Ment Dis 1988;176:457-464 (Pubitemid 18215725)
14. Harvey NS, Peet M. Lithium maintenance, 2: effects of personality and attitude on health information acquisition and compliance. Br J Psychiatry 1991;158:200-204
15. Schumann C, Lenz G, Berghöfer A, et al. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res 1999;89:247-257 (Pubitemid 30053007)
16. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002;105:164-172 (Pubitemid 34280688)
17. Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry 1979;36:866-869 (Pubitemid 10107677)
18. Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J Affect Disord 2000;59:237-241 (Pubitemid 30347547)
19. Harvey NS. The development and descriptive use of the Lithium Attitudes Questionnaire. J Affect Disord 1991;22:211-219
20. Post RM, Frye MA, Denicoff KD, et al. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1998;19:206-219 (Pubitemid 28302578)
21. Greil W, Ludwig-Mayerhofer W, Steller B, et al. The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders. J Affect Disord 1993;28:257-265 (Pubitemid 23240263)
22. Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders: a randomized study. J Affect Disord 1997;43:151-161 (Pubitemid 27219568)
23. Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Lithium versus carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Eur Arch Psychiatry Clin Neurosci 1997;247:42-50 (Pubitemid 27113062)
24. Kleindienst N, Greil W. Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder. Psychol Med 2002;32:493-501 (Pubitemid 34308793)
25. Greil W, Kleindienst N, Erazo N, et al. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998;18:455-460 (Pubitemid 28555328)
26. Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord 1996;40:179-190 (Pubitemid 26338517)
27. Linden M, Nather J, Wilms HU. Zur Definition, Bedeutung und Messung der Krankheitskonzepte von Patienten. Die Krankheitskonzeptskala (ICS-Skala) für schizophrene Patienten. Fortschr Neurol Psychiatr 1988;56:35-43
28. Ludwig W, Huber D, Schmidt S, et al. Assessment of compliance-related attitudes in psychiatry: a comparison of two questionnaires based on the Health Belief Model. Soc Psychiatry Psychiatr Epidemiol 1990;25:298-303
29. Linden M, Godemann F, Gaebel W, et al. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years. Schizophr Bull 2001;27:585-596 (Pubitemid 34093245)
30. von Zerssen D, Pfister H, Koeller DM. The Munich Personality Test (MPT): a short questionnaire for self-rating and relatives' rating of personality traits: formal properties and clinical potential. Eur Arch Psychiatry Neurol Sci 1988;238:73-93 (Pubitemid 19020802)
31. Sauer H, Richter P, Czernik A, et al. Personality differences between patients with major depression and bipolar disorder: the impact of minor symptoms on self-ratings of personality. J Affect Disord 1997;42:169-177 (Pubitemid 27170162)
32. Nilsson A, Axelsson R. Psychopathology during long-term lithium treatment of patients with major affective disorders. Acta Psychiatr Scand 1989;80:375-388 (Pubitemid 19263654)
33. Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry 1991;52(suppl 5):28-34
34. Gershon S, Soares JC. Current therapeutic profile of lithium. Arch Gen Psychiatry 1997;54:16-20 (Pubitemid 27044694)
35. Sato T, Bottlender R, Kleindienst N, et al. Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry 2002;159:968-974 (Pubitemid 34586942)
36. Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-1493 (Pubitemid 20015538)
37. Watkins SE, Callender K, Thomas DR, et al. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 1987;150:180-182 (Pubitemid 17010733)
38. Oxtoby A, Jones A, Robinson M. Is your "double-blind" design truly double-blind? Br J Psychiatry 1989;155:700-701
39. Frank E, Swartz HA, Kupfer DJ. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry 2000;48:593-604 (Pubitemid 30702483)
40. Tohen M, Grundy S. Management of acute mania. J Clin Psychiatry 1999;60(suppl 5):31-34 (Pubitemid 29164732)
41. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord 1990;18:259-266 (Pubitemid 20127123)
42. Lenzi A, Lazzerini F, Placidi GF, et al. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry 1989;22:34-37 (Pubitemid 19053583)
43. Gitlin MJ, Cochran SD, Jamison KR. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry 1989;50:127-131 (Pubitemid 19117706)
44. Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis, 1: clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 1988;21:121-125